ft538
Showing 1 - 5 of 5
Cancer, Solid Tumor, Ovarian Cancer Trial in Minneapolis (FT538, Enoblituzumab)
Not yet recruiting
- Cancer
- +4 more
- FT538
- Enoblituzumab
-
Minneapolis, MinnesotaMasonic Cancer Center - University of Minnesota
Jan 24, 2023
HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)
Not yet recruiting
- HIV-1-infection
- +4 more
- FT538
- Vorinostat
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Jan 31, 2023
Solid Tumor, Adult Trial in United States (FT538, Cyclophosphamide, Fludarabine)
Recruiting
- Solid Tumor, Adult
- FT538
- +4 more
-
Hackensack, New Jersey
- +3 more
Apr 14, 2022
Acute Myeloid Leukemia, Myeloid Leukemia, Monocytic Leukemia Trial in Minneapolis (Daratumumab/rHuPH20, FT538, Fludarabine)
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Daratumumab/rHuPH20
- +3 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Nov 3, 2021
Acute Myeloid Leukemia, AML, Adult, Multiple Myeloma Trial in United States (FT538, Cyclophosphamide, Fludarabine)
Recruiting
- Acute Myeloid Leukemia
- +3 more
- FT538
- +4 more
-
Denver, Colorado
- +8 more
May 19, 2022